SCHEMBL17208955

SCHEMBL17208955

CCC(CC)C(=O)Oc1ccc(/N=N/c2ccc(C#N)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 2/20 0.46
▸ PPARD Q03181 2/20 0.46
▸ PPARA Q07869 2/20 0.46
▸ ELANE P08246 1/20 0.42
▸ MAPT P10636 3/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ RAB9A P51151 1/20 0.40
▸ HRH3 Q9Y5N1 2/20 0.39
▸ CYP11B1 P15538 1/20 0.39
▸ CYP11B2 P19099 1/20 0.39
▸ CYP1B1 Q16678 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ MMP2 P08253 1/20 0.39
▸ MMP3 P08254 1/20 0.39
▸ F2 P00734 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13750796 0.88 MGLL (0.45) MGLLPPARDPPARAELANEMAPT
SCHEMBL12691162 0.88 MGLL (0.45) MGLLPPARDPPARAELANEMAPT
SCHEMBL18512374 0.82 ELANE (0.46) PPARDPPARAELANEMAPTALDH1A1
SCHEMBL17203077 0.81 ELANE (0.45) MGLLPPARDPPARAELANEMAPT
SCHEMBL17203078 0.81 ELANE (0.45) MGLLPPARDPPARAELANEMAPT
SCHEMBL9421250 0.81 L3MBTL1 (0.56) MGLLMAPTALDH1A1RAB9AHRH3
SCHEMBL6323128 0.79 ELANE (0.49) MGLLPPARDPPARAELANEMAPT
SCHEMBL19215818 0.79 PPARD (0.42) MGLLPPARDPPARAELANEMAPT
SCHEMBL18512384 0.79 MAPT (0.47) PPARAELANEMAPTALDH1A1RAB9A
SCHEMBL10033505 0.78 MGLL (0.51) MGLLELANEMAPTALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10752780-B2 Chromophores for photochromic compositions useful for three dimensional display applications NITTO DENKO CORPORATION (JP) 2020-08-25 — — US disclosed
US-20170044373-A1 CHROMOPHORES FOR PHOTOCHROMIC COMPOSITIONS USEFUL FOR THREE DIMENSIONAL DISPLAY APPLICATIONS NITTO DENKO CORPORATION (JP) 2017-02-16 — — US disclosed
US-20170044373-A1 CHROMOPHORES FOR PHOTOCHROMIC COMPOSITIONS USEFUL FOR THREE DIMENSIONAL DISPLAY APPLICATIONS NITTO DENKO CORPORATION (JP) 2017-02-16 — — US disclosed
WO-2015164390-A1 CHROMOPHORES FOR PHOTOCHROMIC COMPOSITIONS USEFUL FOR THREE DIMENSIONAL DISPLAY APPLICATIONS NITTO DENKO CORPORATION (JP) 2015-10-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10752780-B2 Chromophores for photochromic compositions useful for three dimensional display applications CRY1, RB1, BRD3 MGLL 4038/4885PPARD 1230/4885PPARA 1313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback